Simplify Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,277
Closed -$1.99M 104
2024
Q3
$1.99M Buy
29,277
+11,800
+68% +$666K 0.09% 54
2024
Q2
$738K Sell
17,477
-46,550
-73% -$2.56M 0.05% 77
2024
Q1
$4.42M Buy
64,027
+55,046
+613% +$3.48M 0.26% 31
2023
Q4
$664K Sell
8,981
-654
-7% -$42.9K 0.06% 84
2023
Q3
$657K Sell
9,635
-12,498
-56% -$1.06M 0.08% 87
2023
Q2
$2.08M Buy
+22,133
New +$1.73M 0.27% 56

Other funds holding EXAS

Simplify Asset Management's EXAS Position: Q4 2024 in Review

Simplify Asset Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 29,277 shares — an estimated $1.99M sold.

Simplify Asset Management first reported a position in EXAS in Q2 2023 and held it in 6 quarters. The position peaked at $4.42M in Q1 2024. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Simplify Asset Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Simplify Asset Management sold 29,277 Exact Sciences shares in Q4 2024, an estimated $1.99M.
  • Simplify Asset Management first reported a position in Exact Sciences in Q2 2023 and held it in 6 quarters.
  • Simplify Asset Management's Exact Sciences position peaked at $4.42M in Q1 2024.
  • 592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.